A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
March 1st, 2022
The present protocol describes a surgical procedure to remove ascending-aortic banding in a rat model of pulmonary hypertension due to left heart disease. This technique studies endogenous mechanisms of reverse remodeling in the pulmonary circulation and the right heart, thus informing strategies to reverse pulmonary hypertension and/or right ventricular dysfunction.
Overview
This protocol outlines a surgical procedure for removing ascending aortic banding in a rat model of pulmonary hypertension due to left heart disease. The technique is essential for studying the mechanisms of reverse remodeling in the pulmonary circulation and right heart, aiding in the development of treatments for pulmonary hypertension.
Key Study Components
Area of Science
- Cardiovascular physiology
- Pulmonary hypertension research
- Surgical techniques in animal models
Background
- Ascending aortic banding is a model for studying pulmonary hypertension.
- Understanding reverse remodeling can inform treatment strategies.
- Right ventricular dysfunction is a critical aspect of pulmonary hypertension.
- This study utilizes a rat model to explore these mechanisms.
Purpose of Study
- To investigate the effects of removing aortic banding on pulmonary hypertension.
- To study the physiological mechanisms of reverse remodeling.
- To develop potential therapeutic strategies for pulmonary hypertension.
Methods Used
- Preparation of surgical instruments.
- Positioning and anesthetizing the rat.
- Disinfecting the surgical area.
- Monitoring for signs of previous surgical interventions.
Main Results
- The surgical procedure effectively reverses pulmonary hypertension.
- Physiological reverse remodeling is observed in the pulmonary circulation.
- Right ventricular function improves post-surgery.
- This model provides insights into treatment strategies for pulmonary hypertension.
Conclusions
- The removal of ascending aortic banding is a viable method for studying pulmonary hypertension.
- This technique enhances understanding of reverse remodeling mechanisms.
- Findings may contribute to developing new therapies for pulmonary hypertension.
Frequently Asked Questions
Executive Industry Relevance
Reverse vascular remodeling in pulmonary hypertension due to left heart disease (PH-LHD) represents a critical inflection point for target validation and mechanistic de-risking in cardiovascular drug discovery. This rat model of aortic debanding enables direct interrogation of physiological reversal processes, supporting predictive confidence for translational strategies targeting pulmonary vascular and right ventricular remodeling. The approach provides a platform for evaluating therapeutic hypotheses in disease-relevant systems where clinical options remain limited.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables mechanistic interrogation of reverse remodeling pathways in PH-LHD.
- Supports functional target validation by linking molecular changes to physiological outcomes.
- Facilitates biological de-risking for candidate targets affecting pulmonary and right ventricular remodeling.
- Provides a disease-relevant system for hypothesis testing in preclinical research.
Screening & Assay Development
- Establishes a validated in vivo model for quantitative assessment of cardiac and pulmonary endpoints.
- Supports reproducible measurement of right ventricular systolic pressure and hypertrophy reversal.
- Enables standardization of biomarker readouts such as BNP and echocardiographic parameters.
- Prepares the foundation for downstream compound evaluation in PH-LHD contexts.
Translational & Preclinical Research
- Aligns preclinical findings with clinical scenarios of mechanical unloading in heart failure patients.
- Provides continuity from discovery through preclinical validation of reverse remodeling interventions.
- Supports risk-adjusted advancement decisions for therapies targeting pulmonary vascular remodeling.
- Offers predictive de-risking for translational biomarker strategies in PH-LHD.
Pipeline & Workflow Integration
This model integrates into the discovery-to-preclinical continuum for cardiovascular and pulmonary vascular research, bridging early mechanistic studies with translational validation.
- Discovery Biology: Enables hypothesis testing on the reversibility of vascular and cardiac remodeling in PH-LHD.
- Screening: Provides quantitative, reproducible endpoints for evaluating intervention efficacy.
- Analytics: Delivers measurable outputs such as RV systolic pressure, hypertrophy indices, and biomarker normalization.
- Translational Research: Connects preclinical findings to clinical scenarios involving mechanical unloading and reverse remodeling.
- Enterprise Reuse: Serves as a reusable platform for diverse mechanistic and therapeutic studies in PH-LHD and related conditions.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in PH-LHD target validation.
- Operational Value: Standardizes in vivo assessment of reverse remodeling with reproducible, quantitative outputs.
- Strategic Value: Informs go/no-go decisions and capital allocation for PH-LHD therapeutic programs.
- Portfolio Impact: Enables risk-adjusted prioritization of candidates targeting pulmonary vascular and right ventricular remodeling.
Implementation Considerations
- Requires expertise in rodent cardiovascular surgery and perioperative care.
- Demands access to echocardiography, Doppler imaging, and biomarker analysis platforms.
- Necessitates cross-team standardization of surgical and analytical protocols.
- Adaptation may be needed for other species or heart failure etiologies.
- Critical procedural steps, such as clip removal and lung recruitment, directly impact model reliability and survival.
Biopharma FAQs
Chapters in this video
0:05
Introduction
0:42
Surgical Preparations and Tracheotomy and Mechanical Ventilation
2:24
Aortic Debanding
4:06
Tracheal Extubation and Post-Operative Care
5:19
Results: Analysis of Aortic Blood Flow, Ventricular Function, and Hemodynamics after Debanding Surgery
7:09
Conclusion
